EasyManua.ls Logo

Vitek AST-GN75 - Quality Control

Vitek AST-GN75
4 pages
Print Icon
To Next Page IconTo Next Page
To Next Page IconTo Next Page
To Previous Page IconTo Previous Page
To Previous Page IconTo Previous Page
Loading...
VITEK
®
2 AST-GN75 9310655-P1EN1 - 2015/08
bioMérieux SA English - 2
Piperacillin PIP! 4, 16, 32, 64 4 128
Acinetobacter spp., Enterobacter spp.,
E. coli, Klebsiella spp., M. morganii,
Pv. rettgeri, P. mirabilis, P. vulgaris,
P. aeruginosa, Serratia spp., B. cepacia,
C. koseri, C. freundii, P. fluorescens,
C. sakazakii
Tobramycin TM 8, 16, 64 1 16 CSAGNB**
Trimethoprim/Sulfamethoxazole SXT
!
1/19, 4/76, 16/304 20 (1/19) 320 (16/304)
Klebsiella spp., Enterobacter spp.,
M. morganii, P. vulgaris, P. mirabilis,
S. sonnei, S. flexneri, Eco(+ETEC)**,
C. sakazakii
Numerical values are expressed in µg/ml.
§ Equivalent standard method concentration by efficacy.
**CSAGNB = Clinically significant aerobic gram negative bacilli
c
= Category agreement was established at the time of FDA clearance. Essential agreement was not established since
test contains less than five discrete dilutions.
**Kox(-ESBL) = K. oxytoca (excluding ESBL producing strains)
Note: For ESBL, FEP is Cefepime, CTX is Cefotaxime, CAZ is Ceftazidime and CA is Clavulanic Acid. For ESBL positive
strains, the test interpretation should be reported as resistant for all penicillins, cephalosporins, and aztreonam.
NEG = Negative
POS = Positive
A negative ESBL test result does not rule out the presence of an ESBL masked by an AmpC beta-lactamase.
",! etc. = See performance characteristics identified by the drug code with this symbol in the Comment column in
Systems Product Information.
**Eco(+ETEC) = E. coli (including susceptible enterotoxigenic strains implicated in traveler's diarrhea)
QUALITY CONTROL
CLSI
®
Quality Control Organisms VITEK 2 Results
Antimicrobic Code
E. coli
ATCC® 25922™
P. aeruginosa
ATCC® 27853™
E. coli
ATCC® 35218™
K. pneumoniae ssp pneumoniae
ATCC® 700603™
Amikacin AN 2 – 4 2 – 4 - -
Ampicillin AM 2 – 8 - - -
Ampicillin/Sulbactam SAM 2/1 – 8/4 - 8/4 – 32/16 -
Cefazolin CZ 4 - - -
Cefepime FEP 1 1 – 8 - -
Cefoxitin FOX 4 – 8 - - -
Ceftazidime CAZ 1 1 – 4 - -
Ceftriaxone CRO 1 8 64 - -
Ciprofloxacin CIP 0.25 0.25 – 1 - -
Ertapenem
c
ETP 0.5 2 8 - -
ESBL
,
ESB NEG - - POS
Gentamicin GM 1 1 – 2 - -
Levofloxacin LEV 0.12 0.5 4 - -
Meropenem MEM 0.25 0.25 – 1 - -
Nitrofurantoin FT 16 - - -
Piperacillin PIP 4 4 – 8 - -
Tobramycin TM 1 1 - -
Trimethoprim/Sulfamethoxazole SXT 20 (1/19) 160 (8/152) 320 (16/304) - -
Numerical values are expressed in µg/ml.
c
= Category agreement was established at the time of FDA clearance. Essential agreement was not established since
test contains less than five discrete dilutions.
Note: For ESBL, FEP is Cefepime, CTX is Cefotaxime, CAZ is Ceftazidime and CA is Clavulanic Acid. For ESBL positive
strains, the test interpretation should be reported as resistant for all penicillins, cephalosporins, and aztreonam.
NEG = Negative
POS = Positive
A negative ESBL test result does not rule out the presence of an ESBL masked by an AmpC beta-lactamase.

Related product manuals